PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript
Source: SeekingAlpha
2025-12-10 16:42:55 ET
PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections December 10, 2025 11:30 AM EST...
Read the full article on Seeking Alpha
For further details see:
PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript
PolyPid Ltd.
NASDAQ: PYPD
PYPD Trading
-0.72% G/L:
$4.15 Last:
23,280 Volume:
$4.275 Open:
PYPD Latest News
February 11, 2026 07:30:00 am
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
PYPD Stock Data
$48,610,612
10,017,659
N/A
8
N/A
Biotechnology & Life Sciences
Healthcare
IL
Petach Tikva
